Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |